doi: 10.1139/cjpp-2017-0683 Summary Keywords GLP-1, Alzheimers disease, blood pressure, DPP-4, non-alcoholic steatohepatitis, signaling pathway Citation Li Q-X, Gao H, Guo Y-X, Wang B-Y, Hua R, Gao L, Shang H-W, Lu X and Xu J-D (2021) GLP-1 and Underlying Beneficial Actions in Alzheimers Disease, Hypertension, and NASH
Studies show that gastroparesis may be one of many significant risks associated with the use of GLP-1 drugs like Ozempic
Theyre now required to stop producing compounded versions within a few months
It is worth mentioning that VPA is also used for generating an environmental model of ASD by injecting this agent into pregnant mice [211, 212]